Your browser doesn't support javascript.
loading
Ibrutinib for Chronic Graft-versus-Host Disease After Failure of Prior Therapy: 1-Year Update of a Phase 1b/2 Study.
Waller, Edmund K; Miklos, David; Cutler, Corey; Arora, Mukta; Jagasia, Madan H; Pusic, Iskra; Flowers, Mary E D; Logan, Aaron C; Nakamura, Ryotaro; Chang, Stephen; Clow, Fong; Lal, Indu D; Styles, Lori; Jaglowski, Samantha.
Afiliación
  • Waller EK; Department of Hematology and Medical Oncology, Winship Cancer Institute of Emory University, Atlanta, Georgia. Electronic address: ewaller@emory.edu.
  • Miklos D; Department of Medicine, Medicine/BMT Division, Stanford University School of Medicine, Stanford, California.
  • Cutler C; Division of Medical Oncology, Dana Farber Cancer Institute, Boston, Massachusetts.
  • Arora M; Department of Hematology, Oncology and Transplant, University of Minnesota, Minneapolis, Minnesota.
  • Jagasia MH; Division of Hematology/Oncology, Vanderbilt-Ingram Cancer Center, Nashville, Tennessee.
  • Pusic I; Division of Oncology, BMT and Leukemia Section, Washington University School of Medicine, St. Louis, Missouri.
  • Flowers MED; Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, Washington.
  • Logan AC; Division of Hematology and Blood and Marrow Transplantation, Department of Medicine, University of California San Francisco, San Francisco, California.
  • Nakamura R; Department of Hematology and Hematopoietic Cell Transplantation, City of Hope National Medical Center, Duarte, California.
  • Chang S; Department of Biostatistics, Pharmacyclics LLC, an AbbVie Company, Sunnyvale, California.
  • Clow F; Department of Biometrics and Data Management, Pharmacyclics LLC, an AbbVie Company, Sunnyvale, California.
  • Lal ID; Department of Clinical Science, Pharmacyclics LLC, an AbbVie Company, Sunnyvale, California.
  • Styles L; Department of Clinical Science, Pharmacyclics LLC, an AbbVie Company, Sunnyvale, California.
  • Jaglowski S; Division of Hematology, Department of Internal Medicine, The Ohio State University Medical Center, Columbus, Ohio.
Biol Blood Marrow Transplant ; 25(10): 2002-2007, 2019 10.
Article en En | MEDLINE | ID: mdl-31260802
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Pirazoles / Pirimidinas / Enfermedad Injerto contra Huésped Tipo de estudio: Prognostic_studies Límite: Female / Humans / Male Idioma: En Revista: Biol Blood Marrow Transplant Asunto de la revista: HEMATOLOGIA / TRANSPLANTE Año: 2019 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Pirazoles / Pirimidinas / Enfermedad Injerto contra Huésped Tipo de estudio: Prognostic_studies Límite: Female / Humans / Male Idioma: En Revista: Biol Blood Marrow Transplant Asunto de la revista: HEMATOLOGIA / TRANSPLANTE Año: 2019 Tipo del documento: Article